Skip to main content

ProQinase, Crelux Team on Crystal-Grade Protein Portfolio Offering

NEW YORK (GenomeWeb News) – ProQinase and Crelux have agreed to a partnership to develop and market crystal-grade protein kinases to pharmaceutical and biotechnology customers, the German companies said today.
 
Under the agreement, ProQinase will produce and exclusively market recombinant protein kinases that are optimized for crystallization, and Crelux will perform quality control for each crystal grade protein batch. Crelux also will continue to provide crystallization and x-ray crystallography services, the firms said.
 
ProQinase also will grant Crelux privileged direct access to kinase crystal-grade proteins. The companies also will offer new crystal-grade protein or crystal structures tailored for specific customers.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.